menu search

Why investors should be watching vertex pharmaceuticals

The company has several big opportunities on the horizon....

February 11, 2022, 7:00 am

Why investors should be watching vertex pharmaceuticals

The company has several big opportunities on the horizon....

February 11, 2022, 7:00 am

Humanigen to present at bio ceo & investor conference

BURLINGAME, Calif. & DUBLIN & LONDON--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopha...

February 11, 2022, 5:55 am

Humanigen to present at bio ceo & investor conference

BURLINGAME, Calif. & DUBLIN & LONDON--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopha...

February 11, 2022, 5:55 am

Humanigen to present at bio ceo & investor conference

BURLINGAME, Calif. & DUBLIN & LONDON--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopha...

February 11, 2022, 5:55 am

Ultragenyx pharmaceutical inc. (rare) ceo emil kakkis on q4 2021 results - earnings call transcript

Ultragenyx pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 9:47 pm

Ultragenyx pharmaceutical inc. (rare) ceo emil kakkis on q4 2021 results - earnings call transcript

Ultragenyx pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 9:47 pm

Ultragenyx pharmaceutical inc. (rare) ceo emil kakkis on q4 2021 results - earnings call transcript

Ultragenyx pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 9:47 pm

Genocea to present at the 11th annual svb leerink global healthcare conference

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceuti...

February 10, 2022, 7:50 pm

Genocea to present at the 11th annual svb leerink global healthcare conference

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceuti...

February 10, 2022, 7:50 pm

Genocea to present at the 11th annual svb leerink global healthcare conference

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceuti...

February 10, 2022, 7:50 pm

In8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T cell therapies bio...

February 10, 2022, 5:36 pm

In8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T cell therapies bio...

February 10, 2022, 5:36 pm

In8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T cell therapies bio...

February 10, 2022, 5:36 pm

West pharmaceutical services (wst) earnings expected to grow: what to know ahead of next week's release

West pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely...

February 10, 2022, 4:08 pm

West pharmaceutical services (wst) earnings expected to grow: what to know ahead of next week's release

West pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely...

February 10, 2022, 4:08 pm

West pharmaceutical services (wst) earnings expected to grow: what to know ahead of next week's release

West pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely...

February 10, 2022, 4:08 pm

Medexus pharmaceuticals, inc. (medxf) ceo ken d'entremont on q3 2022 results - earnings call transcript

Medexus pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript...

February 10, 2022, 12:47 pm

Medexus pharmaceuticals, inc. (medxf) ceo ken d'entremont on q3 2022 results - earnings call transcript

Medexus pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript...

February 10, 2022, 12:47 pm

Medexus pharmaceuticals, inc. (medxf) ceo ken d'entremont on q3 2022 results - earnings call transcript

Medexus pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript...

February 10, 2022, 12:47 pm


Search within

Pages Search Results: